Prostate cancer related dissertations completed in the University of Tampere

Virpi Laitinen

Genetic risk factors for hereditary prostate cancer in Finland – From targeted analysis of susceptibility loci to genome-wide copy number variation study
Acta Electronica Universitatis Tamperensis; 2016
http://urn.fi/URN:ISBN:978-952-03-0144-6

Riikka Nurminen

Genetic Susceptibility Factors for Prostate Cancer at Chromosomal Region 11q13.5
Acta Electronica Universitatis Tamperensis; 2016
http://urn.fi/URN:ISBN:978-952-03-0126-2

Mauro Scaravilli

Identification of 1p21-22 Amplification in Bladder Cancer and Expression of non-coding RNAs in Prostate Cancer
Acta Electronica Universitatis Tamperensis; 22016
http://urn.fi/URN:ISBN:978-952-03-0045-6

Sanna Siltanen

Contribution of the ARLTS1 Gene to Prostate Cancer Susceptibility
Acta Electronica Universitatis Tamperensis; 1325, 2013
http://urn.fi/URN:ISBN:978-951-44-9194-8

Tuomas Kilpeläinen

Population-Based Screening for Prostate Cancer – Weighing up the beneficial and adverse effects of screening
Acta Universitatis Tamperensis : 1745, 2012
http://urn.fi/urn:isbn:978-951-44-8974-7

Saara Lehmusvaara

Traditional and Novel Treatments for Prostate Cancer – Discoveries at the molecular level
Acta Universitatis Tamperensis : 1745, 2012
http://urn.fi/urn:isbn:978-951-44-8845-0

Sanni Jalava

The role of 8q amplification and microRNAs in prostate cancer
Acta Universitatis Tamperensis : 1733, 2012
http://urn.fi/urn:isbn:978-951-44-8814-6

Alfonso Urbanucci

Overexpression of Androgen Receptor in Prostate Cancer
Acta Universitatis Tamperensis : 1693, 2012
http://urn.fi/urn:isbn:978-951-44-8686-9

Teemu Tolonen

Molecular biomarkers and histopathological parameters in prostate cancer diagnostics and prognostics
Acta Universitatis Tamperensis; 1620, 2011
http://urn.fi/urn:isbn:978-951-44-8467-4

Sanna Pakkanen

Profiling of High-risk Prostate Cancer Families in Finland
Acta Universitatis Tamperensis : 1553, 2010
http://urn.fi/urn:isbn:978-951-44-8225-0

Kati Waltering

Androgen receptor signaling pathway in prostate cancer
Acta Universitatis Tamperensis; 1541, 2010
http://urn.fi/urn:isbn:978-951-44-8180-2

Teemu Murtola

Prostate cancer incidence among men using statins, finasteride or antidiabetic drugs.
Acta Universitatis Tamperensis Vol 1482, 2009
http://urn.fi/urn:isbn:978-951-44-7926-7

Henna Mattila

Hereditary prostate cancer in Finland – From genetic linkage to susceptibility genes.
Acta Universitatis Tamperensis Vol 1475, 2009.
http://urn.fi/urn:isbn:978-951-44-7909-0

Hanna Rauhala

DNA hypermethylation in prostate cancer.
Acta Universitatis Tamperensis Vol 1467, 2009.
http://urn.fi/urn:isbn:978-951-44-7884-0

Sari Laitinen

Prostate cancer: from molecular genetics to prognostic markers
Acta Universitatis Tamperensis. Vol 1296, 2008.
http://urn.fi/urn:isbn:978-951-44-7247-3

Tuukka Mäkinen

The Finnish population-based prostate cancer screening trial.
Acta Universitatis Tamperensis Vol 1352, 2008.

Liisa Määttänen

Performance of the Finnish prostate cancer screening trial based on process indicators.
Acta Universitatis Tamperensis Vol 1247, 2007

Eija Seppälä

Heterogeneity in genetic susceptibility to prostate cancer.
Acta Univesitatis Tamperensis. Vol 1188, 2006.
http://urn.fi/urn:isbn:951-44-6769-8

Outi Saramäki

Gene copy number alterations in prostate cancer.
Acta Universitatis Tamperensis. Vol 1162, 2006.
http://urn.fi/urn:isbn:951-44-6679-9

Kimmo Savinainen

Amplification and overexpression of ERBB2, uPA, TRPS1, EIF3S3 and MYC genes in prostate cancer.
Acta Universitatis Tamperensis. Vol 1135, 2006.
http://urn.fi/urn:isbn:951-44-6568-7

Nina Mononen

Polymorphisms in genes associated with androgen biosynthesis and metabolism as risk factors for human prostate cancer.
Acta Universitatis Tamperensis. Vol 1108, 2005.
http://urn.fi/urn:isbn:951-44-6434-6

Annika Rökman

In search of high-penetrant hereditary prostate cancer susceptibility genes in Finland.
Acta Universitatis Tamperensis. Vol 1048, 2004.
http://urn.fi/urn:isbn:951-44-6142-8

Kati Porkka


Differentially expressed genes in prostate cancer.
Acta Universitatis Tamperensis. Vol 959, 2003.
http://urn.fi/urn:isbn:951-44-5772-2

Marika Linja

Alterations in androgen receptor, estrogen receptors and their coregulatory genes in prostate cancer.
Acta Universitatis Tamperensis. Vol 953, 2003.
http://urn.fi/urn:isbn:951-44-5748-X

Mika Matikainen

Genetic epidemiology of hereditary prostate cancer in Finland.
Acta Universitatis Tamperensis. Vol 812, 2001.
http://urn.fi/urn:isbn:951-44-5084-1

Christian Palmberg

Androgen sensitivity of prostate cancer: special reference to prognostic factors and androgen receptor gene amplification.
Acta Universitatis Tamperensis. Vol 779, 2000.
http://urn.fi/urn:isbn:951-44-4954-1

Nina Nupponen

Amplification of EIF3S3 in breast and prostate cancer: from characterization of chromosomal alterations to identification of an amplified target gene.
Acta Universitatis Tamperensis. Vol 712, 1999.
http://urn.fi/urn:isbn:951-44-4700-X

Pasi Koivisto

Androgen receptor gene amplification in hormone-refractory prostate cancer.
Acta Universitatis Tamperensis. Vol 565, 1997

Eija Hyytinen

Molecular cytogenetics of prostate cancer: technology development and analysis of tumor progression.
Acta Universitatis Tamperensis. Ser A, vol 505, 1996.

Tapio Visakorpi

Cell proliferation rate in prostatic carcinomas: prognostic value and relation to epidermal growth factor receptor and p53 expression.
Acta Universitatis Tamperensis. Ser A, vol 342, 1992.